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Many countries developed supportive measures for palliative home care, such as financial
incentives or multidisciplinary palliative home care teams. For policy makers, it is important
to evaluate the use of these national palliative home care supportive measures on a popula-
tion level.
Methods and findings
Using routinely-collected data on all deaths in Belgium in 2012 (n = 107,847) we measured
the use of four statutory supportive measures, specifically intended for patients who have
obtained the legal palliative status, and three non-statutory supportive measures. Factors
associated with uptake were analysed using multivariable logistic regression. Of all deaths
of adult home-dwelling persons in Belgium (n = 87,007), 17.9 percent used at least one stat-
utory supportive measure and 51.5 percent used at least one non-statutory supportive mea-
sure. In those who died of an illness indicative of palliative care needs 33.1 percent used at
least one statutory supportive measure and 62.2 percent used at least one non-statutory
supportive measure. Younger people and persons dying from cancer were more likely to
use a statutory policy measure. Older people and persons dying from COPD were most
likely to use a non-statutory policy measure. Women, non-single people, and those living in
less urbanised areas were most likely to use any supportive measure.
Conclusions
Statutory supportive measures for palliative home care are underused, even in a subpopula-
tion of persons with potential palliative care needs. Policy makers should stimulate an equita-
ble uptake, and reducing the observed inequalities is an important focus for health care policy.
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Introduction
Supportive measures for palliative home care exist in many countries [1,2]. Since the early
1990s, the development of these supportive measures was advocated by the World Health
Organization to meet the growing need for quality palliative care at home, caused by ageing
populations and increases in the number of people living with serious chronic illnesses[3–5].
Despite international differences in how they are financed and what criteria exist to access
them, supportive measures for palliative home care generally exist in the form of financial
incentives, supportive services, or workplace arrangements [6].
The use of hospice and specialist palliative care services has previously been studied in vari-
ous countries[7–10]. A literature review from 2009 on patterns of access to community pallia-
tive care services concluded that patients with certain characteristics (e.g. younger, married,
wealthier, and those with a caregiver at home) were more likely to access specialist palliative
home care services [11]. However, these studies often used qualitative data or small sample
sizes, had a constrained focus (e.g. only cancer patients, one specific palliative care service) or
missed clarity in what they measure. In order to inform the public health policy debate and try
to impact and improve the quality of care at the end-of-life on a population-level, however, it
is important to measure and evaluate policies on that level [12].
Our study uses quality routinely collected data on all deaths in Belgium in 2012. We will
describe the use of supportive measures for palliative home care in the full population of people
who died while living at home, and in a population of those who died of an illness highly indica-
tive of palliative care needs (i.e. neoplasms, COPD, other organ failures, neurodegenerative dis-
eases and HIV/aids) [13,14]. Our research questions are: 1) what was in 2012 the frequency of
the uptake of supportive measures for palliative home care; and 2) what sociodemographic and
disease characteristics are associated with the uptake of these measures?
Methods
Design and setting
This retrospective observational study uses data from all individuals who died in 2012 in Bel-
gium. Supportive measures for palliative home care exist in Belgium since 1985, and have
since been further expanded [15]. Since 2002, palliative care is legally recognised as a right in
Belgium.
Data
Cohort data from eight routinely collected population-level databases, handled by three differ-
ent organisations, were linked. The data consists of (1) the socio-demographic database of all
individuals with healthcare insurance (legally mandatory in Belgium); (2) the health care data-
base containing all reimbursed health care use data on home, nursing home, outpatient and
hospital care; (3) the pharmaceutical database containing all reimbursed medication data; (4)
Belgian Cancer Registry data with diagnostic information on all incidences of cancer including
date of diagnosis and type of cancer; (5) death certificate data containing cause of death; (6)
population registry data including nationality and household composition; (7) census data,
including educational level and housing characteristics and (8) the fiscal database (including
net taxable income).
After acquiring approvals from the relevant data protection agencies, the databases were
linked for analysis in a secure and ethically responsible manner, guaranteeing the anonymity
of the deceased. This process is described elsewhere [16].
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Subjects
To limit the analysis to those who can theoretically use the supportive measures, we excluded
minors and people residing in a nursing home before death from the dataset.
To further limit the analysis to a population that is most likely to benefit from the mea-
sures, we made a second subpopulation of people who died from illnesses highly indicative
of palliative care needs, defined by Rosenwax et al[14] as the ‘Minimal Estimate of potential
users of palliative care’ through mixed-methods research, referred to here as the palliative
subset. The following underlying causes of death were selected using the 10th revision of
the International Statistical Classification of Diseases and Related Health Problems (ICD):
neoplasms (ICD-10 C00-D48), chronic obstructive pulmonary disease (ICD-10 J40-44,
J47), other organ failures (i.e. heart, renal, and liver failure) (ICD-10 I11-I13, I50, K70-72,
N10-12, N18-19), neurodegenerative diseases (i.e. Alzheimer’s, Parkinson’s, motor neu-
rone, and Huntington’s disease) (ICD-10 F01, F03, G10, G12, G20, G30), and HIV/aids
(ICD-10 B20-24).
Terms and classification of supportive measures
We defined supportive measures for palliative home care as: ‘all health care allowances and ser-
vices (in addition to the standard primary care services) that can support the patient to remain
at home in the last phase of life’. We divided supportive measures for palliative home care into
statutory and non-statutory:
Statutory supportive measures for palliative home care. These supportive measures are
specifically intended for patients who have obtained the legal ‘palliative status’, acquired after
being diagnosed as: suffering from one or multiple irreversible diseases, progressing in an
unfavourable direction, with serious physical/mental deterioration, where therapeutic and
rehabilitative interventions no longer affect deterioration, the prognosis is poor and death is
expected in the relatively short term (life expectancy of more than 24 hours and less than three
months), having serious physical, psychological, social and existential needs requiring signifi-
cant time-intensive and sustained support, and remaining or having the intention of dying at
home [17]. The general practitioner of the patient (or another medical doctor) should formally
make this diagnose to be able to receive these measures:
1) The use of a multi-disciplinary palliative home care team, which provides expertise to gen-
eral practitioners, health professionals, counsellors, informal carers and volunteers. They
consist of at least one team doctor, an administrative force and palliative experts (mainly
nurses). It is free of charge and not limited in time;
2) Nursing care at home for patients with the palliative status. Palliative nurses are available to
patients at home round-the-clock, have a basic training in palliative care, and need to add
specific information to the nursing record (e.g. registration of symptoms, the pain scale). It
is free of charge and not limited in time;
3) Physiotherapy at home for patients with the palliative status. It is free of charge and not lim-
ited in time;
4) The allowance for palliative home patients, a lump sum of € 647.16 (in 2012), obtainable
twice and meant to cover for non-reimbursed costs related to the provision of palliative
care in the home. The amount is fixed for all patients.
Apart from these measures, all out-of-pocket costs for general practitioner consultations
are abolished for these patients.
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Non-statutory supportive measures for palliative home care.
1) Nursing care at home for heavily dependent home-patients. The out-of-pocket rate for
heavily dependent patients depends on their level of care dependency (not free);
2) Physiotherapy at home for heavily dependent home-patients. The out-of-pocket rate for
heavily dependent patients depends on their level of care dependency (not free);
3) The allowance for chronically ill patients, a lump sum of up to €576.10 (in 2012) for heavily
care-dependent people who have exceeded a certain amount of out-of-pocket costs for care
in two consecutive years. The amount is linked to the level of care dependency (divided
into three levels).
Sociodemographic characteristics
Population characteristics available through the datasets are: age at death, sex, nationality,
household type, housing comfort, educational level (using UNESCO’s International Standard
Classification of Education (ISCED)), region, degree of urbanisation, annual personal net tax-
able income and underlying cause of death (using the 10th revision of the International Classi-
fication of Diseases (ICD-10), categorized as: neoplasms, COPD, other organ failure,
neurodegenerative disease, HIV/aids, other). For codification clarifications and detailed infor-
mation on data administrators and data sources see S1 Appendix.
Data analysis
Descriptive statistics were used to describe population characteristics in the full population
and in the palliative subset. To compare the chances of receiving a policy measure to support
palliative home care between different population groups a multivariable binary logistic
regression was performed with uptake (of a statutory measure, a non-statutory measure, or
one or more of all measures) as the dependent variable. A hierarchical approach was followed
to build the model (see S1 Appendix). An alternative model was analysed on a subgroup of
only cancer deaths (see S1 Table). The analyses were generated using the SAS Enterprise
Guide 7.1 software.
Ethics approvals
This study received approvals by the Commission for Medical Ethics of the University Hospi-
tal Brussels (B.U.N. 143201629410). Trusted Third Parties (TTPs) ‘eHealth’ and ‘Crossroads
Bank for Social Security (CBSS)’ were responsible for the deidentification process and deter-
ministic one-to-one record linkage of the databases. In accordance with Belgian law, approvals
for access to and integration of the various databases were obtained from two separate national
sectoral committees for privacy protection: the ‘Sectoral Committee of Social Security and
Health, Section Health’ and the ‘Statistical Supervisory Committee’. Both are subcommittees
of the Belgian Commission for the Protection of Privacy. No informed consent was required.
For a full description of the data linkage procedure, including details on the data anonymiza-
tion, see Maetens et al.[16].
Results
Population characteristics
In 2012, 87,007 health-insured adult persons died in Belgium while living at home (Table 1).
Of these, 38,657 died from a cause indicative of palliative care need: 29.5% died from a
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Table 1. Characteristics of all deaths and deaths of persons with potential palliative care needs (in %).












Underlying cause of death
Neoplasms 29.5 66.4
Other organ failure 5.6 9.4
COPD 4.3 9.6






Single person household 38.7 34.6
Married 47.6 52.6
Living together 4.3 4.1







Below basic level 9.6 8.5
Missinga 9.4 7.7
Education level
No primary education 8.6 8.1
Primary school education 34.8 34.7
Secondary school education 45.1 45.0
Post-secondary school education 11.5 12.2
Missinga 13.1 11.1
Income level
Q1 (lowest to €12,221) 26.7 27.0
Q2: (€12,222 to €14,497) 23.2 22.5
Q3: (€14,498 to €18,346) 24.4 24.7
Q4: (18,347 to highest) 25.7 25.7
Missinga 4.1 2.1
Region
Brussels Capital region 9.2 8.3
(Continued)
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neoplasm, 4.3% from COPD, 5.6% from another organ failure, 5% from neurodegenerative
disease, and 0.04% from HIV/aids.
Uptake of supportive measures for palliative home care
Of all home-dwelling adults, 17.9% used a statutory measure, 51.5% a non-statutory measure,
55.2% at least one supportive measure, and 14.1% at least one statutory and non-statutory
measure (Table 2).
Of those in the palliative subset, 33.1% used a statutory and 62.2% a non-statutory measure;
69.7% used at least one of each, and 25.7% used both (see S2 Table). The statutory and non-
statutory measures were used by 42.7% and 62.3% respectively of those dying of neoplasms,
Table 1. (Continued)
All deaths Palliative subset
Walloon region 35.7 32.8
Flemish region 55.1 59.0
Missinga 1.9 0.7
Urbanisationc






aAll percentages are presented as valid percentages. Percentages for missing values are calculated separately.
b Housing standard was operationalised by the national bureau for statistics and was based on several criteria of
comfort, e.g. ‘having a toilet and bathroom with bath and/or shower’, ‘having central heating’, ‘having a kitchen of
min. 4m2’. For the detailed operationalisation, see S1 Appendix.
c Degree of urbanisation was operationalised by the national bureau for statistics and was based on morphological
and functional level of urbanisation (strong or weak). For the detailed operationalisation, see S1 Appendix.
https://doi.org/10.1371/journal.pone.0213731.t001
Table 2. The use of supportive measures for palliative home care (in %).
All deaths� Palliative subset
Number (n) 87,007 38,657
Statutory palliative home care measures 17.9 33.1
Allowance for palliative home patients 16.0 30.4
Multi-disciplinary support team 8.6 17.1
Nursing care for palliative home patients 12.7 23.7
Physiotherapy for palliative home patients 4.0 7.1
Non-statutory palliative home care measures 51.5 62.2
Nursing care for heavily dependent persons 29.7 34.6
Physiotherapy for heavily dependent persons 24.4 25.4
Allowance for chronically ill patients 29.2 38.4
Used one of the above measures 55.2 69.7
Used a ‘statutory’ and a ‘non-statutory’ measure 14.1 25.7
Patients were able to receive several measures at once, thus numbers of uptake do not add up.
�All deaths of adult persons not residing in a nursing home in the last year of life.
https://doi.org/10.1371/journal.pone.0213731.t002
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11.4% and 65.6% of COPD, 13.1% and 61.7% of other organ failures, 17.7% and 59.8% of
neurodegenerative diseases, and 5.9% and 32.4% of HIV/aids.
Characteristics associated with uptake of a supportive measure for
palliative home care
Multivariable logistic analysis for the palliative subset indicated that those under 65 years were
significantly more likely to use a statutory measure compared to those above 95 years old
(Odds Ratio = 1.32; 95% Confidence Interval [1.07–1.62]), but not a non-statutory measure
(Table 3). The age groups between 65 years old and 94 years old were not significantly more or
less likely to use a statutory measure compared to those aged over 95, but significantly more
likely to use a non-statutory measure. Age was not a significant predictor for the use of either a
statutory or non-statutory measure (third model). Women were more likely to use a statutory
(OR = 1.10[1.04–1.16]) or non-statutory (OR = 1.35[1.28–1.41]) measure than men. Com-
pared with those who died from neoplasms, people who died from COPD (OR = 0.18[0.16–
0.20]), other organ failures (OR = 0.22[0.20–0.24]), neurodegenerative disease (OR = 0.30
[0.27–0.33]), or HIV/aids (OR = 0.17[0.04–0.72]) were less likely to use a statutory measure.
Compared with people who died from neoplasms, those who died from COPD were more
likely to use a non-statutory measure (OR = 1.22[1.13–1.32]), but those who died from neuro-
degenerative diseases (OR = 0.86[0.80–0.92]) or from HIV/aids (OR = 0.41[0.18–0.94]) were
less likely to receive such a measure. Results predicting the use of a non-statutory measure
were not significant for those who died from other organ failure.
People who were married (OR = 1.75[1.65–1.86]), living together (OR = 1.34[1.18–1.53]),
forming a one-parent family (OR = 1.27[1.14–1.41]), or being part of another sort of house-
hold (OR = 1.35[1.15–1.58]) were more likely to use at least one of all supportive measures
than those living alone. People living in the Flemish (OR = 1.33[1.20–1.46]) or in the Walloon
region (OR = 1.15[1.03–1.27]) were more likely to receive at least one of all measures than
those living in the Brussels Capital region. People living in an area with a lower degree of
urbanisation were more likely to use a supportive measure than those in an area with a higher
degree of urbanisation.
Educational level was found to be a significant predictor of supportive measure use only in
the group with post-secondary school education, and only for the use of a non-statutory mea-
sure (OR = 1.22[1.10–1.36]) or for any supportive measures (OR = 1.13[1.00–1.27]). Having
higher standard housing is a significant predictor of statutory measure use, of any measure
use, but not of non-statutory measure use. Nationality was included in the analyses but was
found not to be significant.
Discussion
Using linked data of all deaths in Belgium in 2012, this study found that the uptake of support-
ive measures for palliative home care in a population with potential palliative care needs was
relatively low. Only a third used a statutory measure (33.1%). The use of non-statutory mea-
sures was found to be more frequent in this population (62.2%). Statutory measures were
more likely to be used by younger people and those with neoplasms, non-statutory measures
by older people and those dying of COPD.
Strengths and limitations
To our knowledge, this is the first study to measure uptake of both statutory and non-statutory
supportive measures for palliative home care on a population-level. In Belgium, membership to
one of the seven national health insurers is mandatory for the full population, thus the data cover
The use of supportive measures for palliative care
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Table 3. Factors associated with the use of supportive measures for palliative home care in the palliative subset population (n = 32,075).
Statutory Non-statutory Statutory or non-statutory
OR 95% CI OR 95% CI OR 95% CI
Age
18–64 1.32 (1.07–1.62) 1.09 (0.93–1.28) - -
65–74 1.19 (0.97–1.47) 1.20 (1.02–1.40) - -
75–84 1.10 (0.89–1.34) 1.22 (1.05–1.43) - -
85–94 0.97 (0.79–1.20) 1.19 (1.02–1.39) - -
94+ ref - ref - ref -
Sex
Male ref - ref - ref -
Female 1.10 (1.04–1.16) 1.35 (1.28–1.41) 1.3 (1.23–1.37)
Cause of death
Neoplasm ref - ref - ref -
Other organ failure 0.22 (0.20–0.24) 1.0 (0.93–1.08) 0.68 (0.63–0.73)
COPD 0.18 (0.16–0.20) 1.22 (1.13–1.32) 0.82 (1.75–0.89)
Neurodegenerative disease 0.30 (0.27–0.33) 0.86 (0.80–0.92) 0.61 (0.56–0.66)
HIV/aids 0.17 (0.04–0.72) 0.41 (0.18–0.94) 0.36 (0.15–0.87)
Household composition
Single person household ref - ref - ref -
Married 1.76 (1.65–1.87) 1.64 (1.55–1.73) 1.75 (1.65–1.86)
Living together 1.42 (1.24–1.62) 1.28 (1.14–1.44) 1.34 (1.18–1.53)
One-parent family 1.35 (1.21–1.52) 1.24 (1.12–1.36) 1.27 (1.14–1.41)
Other 1.40 (1.18–1.65) 1.25 (1.08–1.44) 1.35 (1.15–1.58)
Housing standard
Below low ref - ref - ref -
High 1.28 (1.16–1.42) - - 1.37 (1.25–1.51)
Average 1.10 (0.98–1.23) - - 1.15 (1.04–1.28)
Low 1.14 (1.02–1.27) - - 1.19 (1.09–1.31)
Education level
No education ref - ref - ref -
Primary school education - - 0.99 (0.90–1.08) 0.94 (0.86–1.04)
Lower secondary school education - - 1.05 (0.96–1.14) 0.97 (0.88–1.07)
Post-secondary school education - - 1.22 (1.10–1.36) 1.13 (1.00–1.27)
Income level
Q1 (lowest) ref - ref - ref -
Q2 1.06 (0.99–1.15) 1.05 (0.99–1.13) 1.08 (1.01–1.16)
Q3 1.01 (0.94–1.09) 1.13 (1.06–1.21) 1.12 (1.01–1.21)
Q4 (highest) 0.93 (0.87–1.00) 1.15 (1.07–1.23) 1.06 (0.99–1.14)
Region
Brussels-capital region ref - ref - ref -
Walloon region 1.14 (1.01–1.29) 1.17 (1.06–1.29) 1.15 (1.03–1.27)
Flemish region 1.73 (1.54–1.94) 1.15 (1.04–1.26) 1.33 (1.20–1.46)
Urbanisation
Very high ref - ref - ref -
High 1.17 (1.09–1.26) 1.1 (1.04–1.17) 1.1 (1.03–1.18)
Average 1.39 (1.29–1.49) 1.31 (1.23–1.40) 1.34 (1.25–1.44)
Low 1.47 (1.34–1.61) 1.28 (1.17–1.39) 1.32 (1.21–1.45)
(Continued)
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(nearly) all individuals. However, additional private insurance is possible, which is not included
in our data. We were able to measure multiple types of supportive measures, such as financial
incentives, supportive home care services and multidisciplinary support teams. The use of linked
data for all Belgian citizens for a given year from routinely-collected administrative, disease-spe-
cific and insurance databases offers a rich, powerful and reliable resource for studying important
public health issues [18,19]. Our data also has its limitations. Although the identification of people
in the palliative subset is based on a previously validated and frequently used estimation, the esti-
mation is based on underlying cause of death, not on an actually observed or stated palliative care
need[14]. Reimbursement data also do not capture other forms of support for palliative home
care (e.g. care given by informal caregivers, services organised outside reimbursement schemes)
or social support (e.g. religious based, kinship networks).
Interpretation of results
Only a third of home-dwelling people with potential palliative care needs made use of a statu-
tory supportive measure for palliative home care. This low uptake is possibly related to the
legal criteria surrounding these measures; in order to be granted legal palliative home patient
status, life expectancy must be estimated as ‘more than 24 hours and less than three months’
[17]. Firstly, prognostication of survival in patients with advanced cancer has been well-
researched, showing consistently that both physicians and patients are unable to correctly pre-
dict their life expectancy, most commonly overestimating it [20–23]. The disease trajectories
of non-cancer serious illnesses are even more unpredictable, further complicating the process
of prognostication [24–26]. Secondly, people confronted with non-cancer illnesses like organ
failure or dementia often see their illness as ‘a way of life’[27] rather than a life-threatening ill-
ness, therefore possibly not perceiving themselves as having palliative home care needs [28–
30]. The possibility of receiving a statutory supportive measure can thus come too late or even
not at all. This hypothesis is supported by findings of a previous study that focussed on the
physician’s reasons for not referring people with life-limiting illnesses to specialist palliative
care services in Belgium in which physicians mentioned ‘not [having] enough time to initiate
palliative care’ as one of the three major reasons for non-referral [13]. Indeed, recent survey
data from Flanders shows that specialised palliative care is initiated with a median of only
twenty days before death [31]. Our finding that younger people and those who died of neo-
plasms were most likely to use statutory supportive measures confirms previous findings [11],
and could be related to the problems of recognising the terminal phase, something frequently
reported to be more difficult in older population groups with chronic illnesses other than can-
cer [32,33].
The uptake of non-statutory supportive measures was higher than statutory supportive
measures. The criteria for these non-statutory supportive measures are based on high care
needs combined with high out-of-pocket costs for two consecutive years, and not on life expec-
tancy, which could explain why they are used more frequently than statutory measures [34–
Table 3. (Continued)
Statutory Non-statutory Statutory or non-statutory
OR 95% CI OR 95% CI OR 95% CI
Rural 1.60 (1.29–1.99) 1.26 (1.03–1.54) 1.32 (1.06–1.65)
Reference category is presented on the left. Exploratory variables that did not significantly add to the model were excluded in the final model; models were built in a
stepwise manner. CI = Confidence Interval. P-value < 0.05 in bold.
https://doi.org/10.1371/journal.pone.0213731.t003
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36]. This could also explain our finding that the chance of using a non-statutory measure was
highest among people who died of COPD, who are prone to high care needs and out-of-pocket
costs [37,38]. It remains unclear, however, whether statutory and non-statutory measures con-
tribute equally to the effective support of palliative home care.
The uptake of supportive measures for palliative home care seems to be influenced,
apart from aspects related to prognosis, by factors such as social support and socio-eco-
nomic position. The higher chances of using statutory and non-statutory measures in
those living with others compared with single-person households suggests that the pres-
ence of social support in the household is an important factor in organising palliative
home care and using supportive measures to do so. The influence of socioeconomic char-
acteristics on the knowledge or use of palliative care has very rarely been studied, and with
differing results [39–41]. Our findings partly suggest a social gradient exists in the use of
supportive measures; the lower likelihood of using non-statutory measures in the lowest
income category can indicate inequality. This result differs from the uptake of statutory
measures, however, where people in the highest income category were significantly less
likely to use these measures when compared with the lowest income category. The better
chances of people with post-secondary education receiving a non-statutory measure may
reflect differences in social capital that give them an advantage in knowing about and
obtaining the measures. The advantage of those living in a home with a high standard of
housing compared with those with a lower standard is an additional indication that there
is some social inequality.
It seems likely that knowledge of existing supportive measures also plays a role. Because pal-
liative care in Belgium has traditionally focussed mainly on cancer patients [42], their advan-
tage in using statutory supportive measures could be due to both oncologists and patients
being better informed. We also found that people living in Flanders were more likely to use a
supportive measure than those in the Brussels Capital region. This may be explained by
regional differences in general information provision and knowledge of palliative care or to
differences in the social environment (e.g. lower social fragmentation in more rural areas) and
national healthcare policy (concentration of large academic hospitals in metropolitan areas
creating a pull factor towards end-of-life care in hospitals) [43].
Suggestions for further research and policy recommendations
Our study is a first step in understanding who makes use of supportive measures for palliative
home care, and who is missing out on them. Future research should focus on how inequalities
in the uptake of these measures influence different outcomes, such as place of death, quality of
care, and costs at the end of life. Additionally, differences in the impact of using statutory or
non-statutory measures on these outcomes should be compared. In this way, public health pol-
icy can be quantitatively evaluated and further improved. Qualitative research also needs to
further examine the motivation and reasons behind the differences in uptake between certain
population groups, and the differences in uptake between statutory and non-statutory support-
ive measures, as these are not registered in administrative data.
The large gap in uptake between statutory and non-statutory supportive measures among a
subgroup of people in potential palliative care need suggests that there remains inequity in
accessing statutory measures. Policy-makers should focus on including underreached groups,
such as older people and those with non-cancer illnesses. The life expectancy criterion to qual-
ify for the statutory supportive measures should be re-evaluated. This is possibly a major bar-
rier that prevents many patients with palliative care needs to make use of them, in particular
older patients and those with a non-cancer diagnosis.
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Conclusion
A relatively large proportion of people who are dying use some supportive measure for pallia-
tive home care. However, the measures specifically intended to support palliative home care
are underused, even in a subpopulation of those who die of an illness indicative of palliative
care needs. Stimulating an equitable uptake of supportive measures intended to support pallia-
tive home care, and reducing the observed social inequalities in their uptake, is an important
focus for health care policy.
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